News
PGNY
21.95
+0.14%
0.03
Progyny (PGNY) Valuation Check After Mixed Share Price Performance And Elevated P/E Multiple
Simply Wall St · 3d ago
Weekly Report: what happened at PGNY last week (0126-0130)?
Weekly Report · 6d ago
Is Progyny (PGNY) Pricing Reflect Future Growth After Recent Share Price Weakness
Simply Wall St · 02/01 01:23
Quant check on health insurers amid Trump admin's proposal for nearly flat Medicare payment rates
Seeking Alpha · 01/27 11:12
Weekly Report: what happened at PGNY last week (0119-0123)?
Weekly Report · 01/26 09:19
Analyst Upgrades Highlight Client Retention And Diversified Revenue Might Change The Case For Investing In Progyny (PGNY)
Simply Wall St · 01/25 04:34
Assessing Progyny (PGNY) Valuation After Citizens Upgrade And Reinforced Client Retention Narrative
Simply Wall St · 01/22 09:48
Progyny price target raised to $35 from $30 at BTIG
TipRanks · 01/21 12:20
PROGYNY INC <PGNY.O>: BTIG RAISES TARGET PRICE TO $35 FROM $30
Reuters · 01/21 11:27
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX
Reuters · 01/21 08:26
Progyny (PGNY) Stock Is Up, What You Need To Know
Barchart · 01/20 14:32
Forecasting The Future: 6 Analyst Projections For Progyny
Benzinga · 01/20 14:01
This Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 01/20 11:28
Progyny Raised to Market Outperform From Market Perform by Citizens
Dow Jones · 01/20 10:32
Progyny Price Target Announced at $30.00/Share by Citizens
Dow Jones · 01/20 10:32
Citizens Upgrades Progyny to Market Outperform, Announces $30 Price Target
Benzinga · 01/20 10:22
Weekly Report: what happened at PGNY last week (0112-0116)?
Weekly Report · 01/19 09:21
Is Progyny (PGNY) Pricing Reflect Its Mixed Returns And Conflicting Valuation Signals
Simply Wall St · 01/16 18:21
1 Profitable Stock to Consider Right Now and 2 We Avoid
Barchart · 01/16 02:32
How Investors Are Reacting To Progyny (PGNY) Raising 2025 Outlook On Stronger Member Engagement
Simply Wall St · 01/15 07:28
More
Webull provides a variety of real-time PGNY stock news. You can receive the latest news about Progyny, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About PGNY
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.